Revista nº 821

Montoya-Madriz S, et al. | COVID-19, co-infecciones y resistencia antimicrobiana 21 Actual Med.2025;110(821):9 -21 Si desea citar nuestro artículo: Montoya-Madriz S, Molina-Mora JA. Asociación entre COVID-19 e infecciones bacterianas. Una revisión de la literatura. Actual Med.2025;110(821):9 -21 .DOI:10.15568/am.2025.82 1.rev01 32. Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, et al. Bacterial co-infection and se- condary infection in patients with COVID-19: a living ra - pid review and meta-analysis. Vol. 26, Clinical Microbio- logy and Infection. Elsevier B.V.; 2020. p. 1622–9. DOI: 10.1016/j.cmi.2020.07.016 33. Bentivegna E, Alessio G, Spuntarelli V, Luciani M, Santi- no I, Simmaco M, et al. Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection. Am J Infect Control. 2021;49(5):640–2. DOI: 10.1016/j.ajic.2020.09.010 34. Kariyawasam RM, Julien DA, Jelinski DC, Larose SL, Rennert-May E, Conly JM, et al. Antimicrobial resistan- ce (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021). Antimicrob Resist Infect Control. 2022;11(1). DOI: 10.1186/s13756- 022-01085-z 35. Gaspar GG, Ferreira LR, Feliciano CS, Campos Júnior CP, Molina FMR, Vendruscolo ACS, et al. Pre-and post-co- vid-19 evaluation of antimicrobial susceptibility for heal - thcare-associated infections in the intensive care unit of a tertiary hospital. Rev Soc Bras Med Trop. 2021;54. DOI: 10.1590/0037-8682-0090-2021 36. Liew Y, Lee WHL, Tan L, Kwa ALH, Thien SY, Cherng BPZ, et al. Antimicrobial stewardship programme: a vital re - source for hospitals during the global outbreak of corona - virus disease 2019 (COVID-19). Int J Antimicrob Agents. 2020;56(5). DOI: 10.1016/j.ijantimicag.2020.106145 37. Luciani M, Bentivegna E, Spuntarelli V, Lamberti PA, Cacioli G, Del Porto F, et al. Recurrent COVID-19 pneumonia in the course of chemotherapy: Consequence of a weakened im - mune system? Vol. 93, Journal of Medical Virology. John Wi - ley and Sons Inc; 2021. p. 1882–4. DOI: 10.1002/jmv.26701 38. Wee LEI, Conceicao EP, Tan JY, Magesparan KD, Amin IBM, Ismail BBS, et al. Unintended consequences of infec- tion prevention and control measures during COVID-19 pandemic. Am J Infect Control. 2021;49(4):469–77. DOI: 10.1016/j.ajic.2020.10.019 39. Shah MM, Patel K, Milucky J, Taylor CA, Reingold A, Ar - mistead I, et al. Bacterial and viral infections among adults hospitalized with COVID-19, COVID-NET, 14 sta - tes, March 2020-April 2022. Influenza Other Respir Viru - ses. 2023;17(3):e13107. DOI: 10.1111/irv.13107 40. Langford BJ, So M, Raybardhan S, Leung V, Soucy J paul R, Westwood D, et al. Antibiotic prescribing in patients with COVID-19 : rapid review and. Clinical Microbio - logy and Infection [Internet]. 2021;27(4):520–31. DOI: 10.1016/j.cmi.2020.12.018 41. Komagamine J, Yabuki T, Matsumoto K, Tanaka N. Eva - luation of Antimicrobial Drug Use and Concurrent Infec- tions during Hospitalization of Patients with COVID-19 in Japan. JAMA Netw Open. 2022;5(2). DOI: 10.1001/jama- networkopen.2022.0040 42. Musuuza JS, Watson L, Parmasad V, Putman-Buehler N, Christensen L, Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and metaanalysis. PLoS One. 2021;16. DOI: 10.1371/journal.pone.0251170 43. Khasawneh AI, Himsawi NM, Abu-Raideh JA, Sammour A, Abu Safieh H, Obeidat A, et al. Prevalence of SARS-COV-2 and other respiratory pathogens among a Jordanian sub - population during Delta-to-Omicron transition: Winter 2021/2022. Liu BM, editor. PLoS One [Internet]. 2023 Mar 30 [cited 2023 May 5];18(3):e0283804. Available from: https://dx.plos.org/10.1371/journal.pone.0283804 DOI: 10.1371/journal.pone.0283804 44. Sreenath K, Batra P, Vinayaraj E V., Bhatia R, SaiKiran K, Singh V, et al. Coinfections with Other Respiratory Patho - gens among Patients with COVID-19. Microbiol Spectr. 2021;9(1). DOI: 10.1128/Spectrum.00163-21 45. Lai HC, Hsu YL, Lin CH, Wei HM, Chen JA, Low YY, et al. Bacterial coinfections in hospitalized children with CO - VID-19 during the SARS-CoV-2 Omicron BA.2 variant pandemic in Taiwan. Front Med (Lausanne). 2023;10. DOI: 10.3389/fmed.2023.1178041 46. Liu R, Wu P, Ogrodzki P, Mahmoud S, Liang K, Liu P, et al. Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response. Sci Rep. 2021;11(1). DOI: 10.1038/s41598-021-92851-3